Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT07084480 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Giant Cell Arteritis - Ways to Precision Medicine

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Record History

See every version on ClinicalTrials.gov ↗

  1. Trial status: Not Yet Recruiting to Recruiting
    • Start date changed from estimate of Aug 1, 2025 to Nov 14, 2025
    • Study sites: 0 to 1
    v3
  2. Secondary endpoints revised (3)
    • Study description shortened, about 7 words
    v2
  3. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Long-term follow-up of aortal adverse events, as well as glucocortioid-associated adverse events in patients with polymyalgia rheumatica (PMR) and giant cell arteritis (GCA).
Trial Details
NCT Number NCT07084480
Lead Sponsor Wuerzburg University Hospital
Conditions
(from sponsor)		 Giant Cell Arteritis, Polymyalgia Rheumatic (PMR)
Related terms Giant Cell Arteritis
Enrollment 400 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov